On March 26, the Supreme Court heard oral arguments in FDA v. Alliance for Hippocratic Medicine, a lawsuit attempting to remove the abortion pill mifepristone from the U.S. market. Mifepristone is now used in approximately two-thirds of abortions in the U.S. While members of the Supreme Court appeared likely to dismiss the case, abortion opponents are working on several other fronts to achieve their goal of banning abortion pills nationwide or restricting access by eliminating telemedicine abortion.

A detailed policy agenda produced by Project 2025, a coalition of 90 right-wing organizations, calls on the next Republican president to direct the FDA to remove the abortion pill mifepristone from the market nationwide.